glp-1 agonist and dpp-4 inhibitor Clinical Use of Inhibitors dpp 4 inhibitor glp 1
Description
Foundayo is a once daily oral treatment for adults with obesity or overweight with weight-related medical problems
Of GLP-1 users with health insurance, more than a quarter say theyre covering the cost entirely out of pocket
Kim S, Jeong J, Jung H-S, Kim B, Kim YE, Lim DS, et al
Yet the real-world data tells a different story
Flint A, Raben A, Blundell JE, Astrup A
January 2019
